![](https://european-biotechnology.com/wp-content/uploads/2024/08/EB.com_Patrik_Stroemberg_AAX-Biotech-267x300.jpg)
AAX Biotech strengthens Board of Directors
Swedish biotech company AAX Biotech AB has welcomed Patrik Strömberg as a new member of the Board of Directors.
New Board Member at biotech start-up AAX Biotech, Patrik Strömberg, brings more than two decades of extensive experience in the pharmaceutical industry and a solid background in research and development, innovation management and business development. He has extensive experience from key positions at pharmaceutical companies such as AstraZeneca and Biovitrum/Sobi. Strömberg has been CEO of AnaCardio since 2021. He holds a PhD in biochemistry from Karolinska Institutet and an MBA from Stockholm University. AAX Biotech was founded by experts from Karolinska Institutet in Stockholm, Sweden.